Colgate-Palmolive stock holds below $90 as investors eye valuation and earnings outlook
Published on 08/21/2026 at 13:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Colgate-Palmolive (ISIN US1941621039) stock last closed at $89.69 on August 20, 2026, leaving the consumer staples heavyweight below the $90 mark and below its recent 52-week high, even as analysts see room for upside with a consensus target of $99.00.
Shares trade below recent highs
According to market data from the MarketScreener highlights page href='https://www.marketscreener.com/quote/stock/COLGATE-PALMOLIVE-COMPANY-41640396/news-key-events/' title='MarketScreener key events for Colgate-Palmolive', Colgate-Palmolive shares closed at $89.69 on August 20, 2026, on the Cboe US venue.
The same overview shows the stock down 1.31% over the latest trading session and down 1.56% since the start of the week as of that August 20, 2026 close, while still up 14.99% since January 1, 2026, underscoring that recent softness comes after a solid year-to-date run.
A separate technical analysis piece from Zacks Investment Research href='https://www.zacks.com/stock/news/2977121/colgate-palmolive-stock-slips-below-50-day-sma-time-to-be-cautious' title='Zacks article on Colgate-Palmolive and its 50-day SMA' notes that Colgate-Palmolive recently rebounded 1.4% in a session to close at $91.46, trading 22.7% above its 52-week low of $74.55 and 7.9% below its 52-week high of $99.33, highlighting that the stock is closer to the upper end of its one-year range but not at peak levels.
Analysts see upside to $99 target
Several institutional positioning updates published on August 21, 2026, point to ongoing investor interest in Colgate-Palmolive shares despite the stock trading below its recent highs.
One filing summary on MarketBeat href='https://www.marketbeat.com/instant-alerts/filing-bank-of-new-york-mellon-corp-boosts-stock-holdings-in-colgate-palmolive-company-cl-2026-08-21/' title='MarketBeat coverage of institutional holdings in Colgate-Palmolive' reports that the company carries an average analyst rating of moderate buy with a consensus target price of $99.00, implying upside of roughly 10% from the August 20, 2026 close at $89.69.
Additional institutional reports compiled on MarketBeat href='https://www.marketbeat.com/instant-alerts/filing-impax-asset-management-group-plc-has-1195-million-stock-holdings-in-colgate-palmolive-company-cl-2026-08-21/' title='MarketBeat summary of Colgate-Palmolive analyst consensus and holdings' similarly cite a moderate buy consensus rating and a $99.00 price objective, reinforcing the view that analysts broadly expect further gains from current levels.
For investors who focus on risk-reward, the fact that Colgate-Palmolive trades 22.7% above its 52-week low yet 7.9% below its 52-week high while analysts see roughly a 10% potential move to their shared $99 target frames the stock as a mature consumer staples name where valuation and earnings delivery will likely determine the next leg of the share price.
Recent earnings backdrop and fundamentals
While the latest institutional-ownership updates highlight demand for Colgate-Palmolive stock, investors still anchor their view in the companys recent earnings trajectory, margins, and cash generation. Recent coverage of the companys quarterly results in 2026 points to steady growth in oral care and personal care categories, supported by pricing actions and resilient demand in key regions.
Financial portals summarizing the most recent reported quarter for Colgate-Palmolive in 2026 describe mid-single-digit organic sales growth in that quarter, driven by higher pricing and a modest contribution from volumes, alongside a year-over-year increase in operating profit as the company works through higher input costs.
These snapshots of the latest quarter suggest that Colgate-Palmolive has been able to protect profitability while passing through cost inflation, an important factor for a company whose value proposition rests on staple brands and recurring household purchases rather than short product cycles.
Consensus data compiled on the MarketScreener consensus page href='https://www.marketscreener.com/quote/stock/COLGATE-PALMOLIVE-COMPANY-152131701/consensus/' title='MarketScreener consensus for Colgate-Palmolive' indicate that analysts on average expect further earnings growth in the current fiscal year, in line with the moderate buy rating profile reflected across several institutional-holding reports on August 21, 2026.
In practical terms, the combination of a year-to-date gain of 14.99% as of August 20, 2026 and an analyst community that still projects earnings expansion illustrates that the market currently prices Colgate-Palmolive as a defensive compounder, rewarding consistent delivery while leaving limited room for disappointment.
Institutional flows underscore confidence
A series of new filings summarized on August 21, 2026 show that multiple asset managers have adjusted their positions in Colgate-Palmolive, which can provide additional context for retail investors following the stock.
One institutional alert on MarketBeat href='https://www.marketbeat.com/instant-alerts/filing-vise-technologies-inc-has-684-million-stock-position-in-colgate-palmolive-company-cl-2026-08-21/' title='MarketBeat alert on Vise Technologies position in Colgate-Palmolive' highlights an asset manager reporting a $6.84 million stock position in Colgate-Palmolive, consistent with the broader narrative that professional investors continue to hold meaningful exposure to the name.
Another MarketBeat filing recap notes that the same moderate buy rating and $99.00 target price appear across different analyst lists, suggesting a relatively unified sell-side view rather than a polarized rating distribution.
Institutional investors often value Colgate-Palmolive for its global footprint, high brand recognition in oral care, and long track record of paying dividends, so the reported positions align with the stocks profile as a core holding in many defensive and income-focused portfolios.
Core toothpaste brand remains central
Beyond the market data and analyst models, Colgate-Palmolives investment case continues to rest heavily on the strength of its flagship Colgate toothpaste franchise, which commands significant market share in many regions worldwide and acts as an anchor for cross-selling other oral-care products.
The companys oral care portfolio typically spans a range of fluoridated toothpastes, whitening products, sensitivity formulations, and childrens variants, with ongoing innovation in areas such as enamel-strengthening ingredients and packaging formats that cater to different markets and price points.
In many emerging markets, Colgate-branded toothpaste plays an outsized role in the companys growth strategy, with unit volumes and distribution expansion contributing to revenue alongside pricing, while in developed markets premium sub-brands and specialized products help support average selling prices and margins.
For equity investors, the durability of the toothpaste franchise helps underpin cash flow visibility, which in turn supports dividends and share repurchases that are often key components of the total return profile for a mature consumer staples issuer like Colgate-Palmolive.
Colgate-Palmolive stock valuation snapshot
At a closing price of $89.69 on August 20, 2026, Colgate-Palmolive stock trades below its recent 52-week high of $99.33 highlighted in the Zacks analysis and modestly below the $99.00 consensus target reported by MarketBeat and MarketScreener, a setup that leaves an implied upside gap yet also embeds the expectation that the company will continue to execute on margin and growth plans.
With the shares up 14.99% year to date as of the August 20, 2026 close according to MarketScreener, the market has already factored in much of the good news on easing input costs and price realization, which is why some technical commentary has focused on the stocks position relative to its 50-day moving average and the possibility of consolidation below recent highs.
For investors monitoring Colgate-Palmolive today, the interplay between defensive characteristics, valuation versus the $99.00 target, and the companys ability to sustain earnings growth will likely drive the stocks direction more than short-term moves in broader indices.
Read more
More on Colgate-Palmolive stock
Flagship Colgate toothpaste franchise
Colgate-Palmolives flagship Colgate toothpaste line remains one of the most recognizable consumer products globally, and its performance directly influences the companys revenue mix and brand equity.
The range includes variants targeting cavity protection, whitening, gum health, sensitivity relief, and childrens oral care, often tailored to local preferences in flavor, formulation, and packaging size, which helps Colgate-Palmolive adapt to differing income levels and retail formats.
Innovation efforts in toothpaste typically involve incremental improvements in active ingredients, such as enhanced fluoride delivery systems or stain-removal agents, as well as sustainability initiatives around recyclable tubes and reduced-plastic packaging, aligning with consumer trends that increasingly weigh environmental factors into purchase decisions.
Because toothpaste is a daily-use product with high repeat-purchase behavior, Colgate-Palmolive benefits from relatively stable demand and can leverage its distribution network across supermarkets, pharmacies, and e-commerce platforms to capture share gains and maintain shelf visibility.
Colgate-Palmolive stock and current pricing
Colgate-Palmolive stock, which is listed in the United States and quoted in USD, last changed hands at $89.69 as of the Cboe close on August 20, 2026, according to MarketScreener, leaving it below the $99.00 consensus analyst target and below the 52-week high of $99.33 referenced in recent technical commentary.
Fact box
Company: Colgate-Palmolive
ISIN: US1941621039
Ticker: CL
Exchange: Cboe US (listing also traded on major US venues)
Price (as of August 20, 2026, 3:59 p.m. ET): $89.69 USD
Market cap: Data consistent with a large-cap US consumer staples company as of late August 2026
Sector / Industry: Consumer staples / Household and personal products
Index membership: S&P 500
